4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0000950170-25-010116
Chief Commercial Officer sold 1,583 shares at $7.87 ($12,461)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powl Brian T. Chief Commercial Officer | 2025-01-28 | Sale | −1,583 | $7.87 | $12,461 | 59,667 | D: show line 1 in the form |
| Open-market sales · 1,583 sh · avg $7.87 · $12,461 | |||||||
Loading xslF345X05/ownership.xml…